AstraZeneca's Baxdrostat achieves breakthrough blood pressure reductions in Phase III Bax24 trial
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
Quest Diagnostics’ blood-based test panels demonstrate confirmatory accuracy, potentially reducing the need for PET imaging
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma
Guidelines aim to establish state-regulated veterinary blood banks
The initiative was announced at World Hypertension Congress, Chennai
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
The initiative aims to empower individuals to take proactive steps towards monitoring their health
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
Subscribe To Our Newsletter & Stay Updated